298 related articles for article (PubMed ID: 8584113)
1. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
3. A new series of photoactivatable and iodinatable linear vasopressin antagonists.
Carnazzi E; Aumelas A; Barberis C; Guillon G; Seyer R
J Med Chem; 1994 Jun; 37(12):1841-9. PubMed ID: 8021923
[TBL] [Abstract][Full Text] [Related]
4. Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin.
Manning M; Bankowski K; Barberis C; Jard S; Elands J; Chan WY
Int J Pept Protein Res; 1992; 40(3-4):261-7. PubMed ID: 1478783
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
7. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
Thibonnier M; Auzan C; Madhun Z; Wilkins P; Berti-Mattera L; Clauser E
J Biol Chem; 1994 Feb; 269(5):3304-10. PubMed ID: 8106369
[TBL] [Abstract][Full Text] [Related]
9. Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.
Ala Y; Morin D; Mahé E; Cotte N; Mouillac B; Jard S; Barberis C; Tribollet E; Dreifuss JJ; Sawyer WH; Wo NC; Chan WY; Kolodziejczyk AS; Cheng LL; Manning M
Eur J Pharmacol; 1997 Jul; 331(2-3):285-93. PubMed ID: 9274991
[TBL] [Abstract][Full Text] [Related]
10. A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors.
Schmidt A; Audigier S; Barberis C; Jard S; Manning M; Kolodziejczyk AS; Sawyer WH
FEBS Lett; 1991 Apr; 282(1):77-81. PubMed ID: 1827414
[TBL] [Abstract][Full Text] [Related]
11. Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonists.
Manning M; Cheng LL; Stoev S; Klis W; Nawrocka E; Olma A; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1997; 3(1):31-46. PubMed ID: 9230469
[TBL] [Abstract][Full Text] [Related]
12. Characterization and localization of oxytocin receptors in the rat testis.
Bathgate RA; Sernia C
J Endocrinol; 1994 May; 141(2):343-52. PubMed ID: 8046305
[TBL] [Abstract][Full Text] [Related]
13. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
Derick S; Cheng LL; Voirol MJ; Stoev S; Giacomini M; Wo NC; Szeto HH; Ben Mimoun M; Andres M; Gaillard RC; Guillon G; Manning M
Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
[TBL] [Abstract][Full Text] [Related]
14. Probing the V1a vasopressin receptor binding site with pyroglutamate-substituted linear antagonists.
Howl J; Yarwood NJ; Stock D; Wheatley M
Neuropeptides; 1996 Feb; 30(1):73-9. PubMed ID: 8868303
[TBL] [Abstract][Full Text] [Related]
15. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
Yibchok-anun S; Hsu WH
Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
17. Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
Serradeil-Le Gal C; Bourrié B; Raufaste D; Carayon P; Garcia C; Maffrand JP; Le Fur G; Casellas P
Biochem Pharmacol; 1994 Feb; 47(4):633-41. PubMed ID: 8129742
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vasopressin and oxytocin receptors in an Australian marsupial.
Bathgate RA; Sernia C
J Endocrinol; 1995 Jan; 144(1):19-29. PubMed ID: 7891021
[TBL] [Abstract][Full Text] [Related]
19. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
Schlosser SF; Almeida OF; Patchev VK; Yassouridis A; Elands J
Endocrinology; 1994 Nov; 135(5):2058-63. PubMed ID: 7956927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
